Key result
In 16 patients undergoing neurointerventional procedures, prasugrel provided immediate therapeutic response with no ischemic or intracranial hemorrhagic complications.
Why the study?
Is prasugrel a safe and effective alternative to clopidogrel for patients undergoing neurointerventional procedures?
Observational (n=16)
No
Is prasugrel a safe and effective alternative to clopidogrel for patients undergoing neurointerventional procedures?
Prasugrel appears to be a viable and safe alternative to clopidogrel for patients undergoing neurointerventional procedures who are clopidogrel non-responders.
No takes yet. Share an insight, caveat, or question.
Prasugrel showed early safety in this small series; leaves open its role as clopidogrel alternative pending larger prospective trials.
Stetler et al. (2012) conducted an observational in Neurointerventional procedures (n=16). Prasugrel was evaluated on Therapeutic response (P2Y12 inhibition) and ischemic or intracranial hemorrhagic complications. In 16 patients undergoing neurointerventional procedures, prasugrel provided immediate therapeutic response with no ischemic or intracranial hemorrhagic complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: